ViewRay Announces Proposed Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Guggenheim Reiterates Buy Rating on ViewRay Inc. (VRAY)
December 3, 2019 9:01 AM ESTGuggenheim analyst Christopher Pasquale reiterated a Buy rating and $8.00 price target on ViewRay Inc. (NASDAQ: VRAY) after the company announced that it has entered into strategic collaborations with both Elekta (EKTAF) and MDT as part of a planned equity financing.
The analyst... More
Baird Reiterates Outperform Rating on ViewRay Inc. (VRAY); 'Financing Monkey Off the Back'
December 3, 2019 8:54 AM ESTBaird analyst Jason Bednar reiterated an Outperform rating and $6.00 price target on ViewRay Inc. (NASDAQ: VRAY) after the company announced proposed financing details, including a $75M raise in which Fosun, Elekta, and Medtronic will participate. As part of their investments, VRAY will partner... More
ViewRay (VRAY) to Resume Trading at 4:30 pm
December 2, 2019 4:14 PM ESTViewRay (NASDAQ: VRAY) to Resume Trading at 4:30 pm
... MoreViewRay (VRAY) Reports Collaborations with Elekta and Medtronic (MDT)
December 2, 2019 4:04 PM ESTViewRay, Inc. (Nasdaq: VRAY) announced today that it has signed a non-binding memorandum of understanding for collaboration with Elekta AB (Nasdaq: EKTA-B.ST) ("Elekta") to advance the knowledge and use of MR-guided radiation therapy. In connection with the collaboration, Elekta has committed to invest capital for up to a 9.9% minority interest in ViewRay, subject to the terms and conditions set forth in a commitment agreement.
Additionally, ViewRay has signed a non-binding memorandum of understanding with Medtronic (NYSE: MDT) to enter into a clinical collaboration in an... More
